Next Article in Journal
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Previous Article in Journal
RAD52: Viral Friend or Foe?
Previous Article in Special Issue
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
 
 
Article

Article Versions Notes

Cancers 2020, 12(2), 409; https://doi.org/10.3390/cancers12020409
Action Date Notes Link
article xml file uploaded 10 February 2020 14:18 CET Original file -
article pdf uploaded. 10 February 2020 14:18 CET Version of Record https://www.mdpi.com/2072-6694/12/2/409/pdf-vor
article supplementary file uploaded. 10 February 2020 14:18 CET - https://www.mdpi.com/2072-6694/12/2/409#supplementary
article xml file uploaded 26 February 2020 14:40 CET Update -
article xml uploaded. 26 February 2020 14:40 CET Update https://www.mdpi.com/2072-6694/12/2/409/xml
article pdf uploaded. 26 February 2020 14:40 CET Updated version of record https://www.mdpi.com/2072-6694/12/2/409/pdf
article html file updated 26 February 2020 14:41 CET Original file -
article html file updated 7 March 2020 06:14 CET Update -
article html file updated 7 March 2020 14:38 CET Update -
article html file updated 20 July 2022 19:46 CEST Update https://www.mdpi.com/2072-6694/12/2/409/html
Back to TopTop